See today's BioWorld MedTech
To read the full story, subscribe or sign in.

AI could overwhelm ability of US FDA to keep up

Dec. 13, 2023
By Mark McCarty
Artificial intelligence has morphed from a buzzword referencing a popular curiosity to a series of national security and competitiveness considerations, which was reflected in the tone of a recent hearing in the U.S. House of Representatives.
BioWorld MedTech Regulatory Artificial intelligence U.S. FDA